Copyright
©The Author(s) 2024.
World J Gastroenterol. Jan 28, 2024; 30(4): 367-380
Published online Jan 28, 2024. doi: 10.3748/wjg.v30.i4.367
Published online Jan 28, 2024. doi: 10.3748/wjg.v30.i4.367
Parameters | n | Cav1.3 expression | P value | |
High, n = 28 | Low, n = 22 | |||
Age | 0.833 | |||
< 65 | 33 | 17 | 16 | |
≥ 65 | 17 | 11 | 6 | |
Gender | 0.231 | |||
Male | 34 | 21 | 13 | |
Female | 16 | 7 | 9 | |
Tumor location | 0.485 | |||
Middle | 30 | 18 | 12 | |
Lower | 20 | 10 | 10 | |
Differentiation | 0.102 | |||
Low | 16 | 8 | 8 | |
Moderate | 21 | 12 | 9 | |
High | 13 | 8 | 5 | |
TNM staging | 0.435 | |||
I | 10 | 6 | 4 | |
II | 27 | 13 | 14 | |
III | 13 | 9 | 4 | |
Lymphatic metastasis | 0.854 | |||
Yes | 22 | 12 | 10 | |
No | 28 | 16 | 12 | |
Hypertension | 0.284 | |||
Yes | 14 | 7 | 7 | |
No | 36 | 21 | 15 |
- Citation: Chen YM, Yang WQ, Gu CW, Fan YY, Liu YZ, Zhao BS. Amlodipine inhibits the proliferation and migration of esophageal carcinoma cells through the induction of endoplasmic reticulum stress. World J Gastroenterol 2024; 30(4): 367-380
- URL: https://www.wjgnet.com/1007-9327/full/v30/i4/367.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i4.367